Blog
A Game Changer for Disease Prevention and Treatment
As diseases continue to emerge, reemerge, and evolve, the development and use of advanced interventions such as monoclonal antibodies are critical for protecting public health …
NFID Flu Bugs #FightFlu with the Washington Nationals
The NFID Flu Bugs encouraged everyone age 6 months and older to get an annual flu vaccine at the 9th Annual Flu Awareness Night with the Washington Nationals
The Implications of Low Vaccination Rates
The implications of low vaccination rates extend well beyond the immediate protection conferred by vaccines against specific pathogens. Long-term benefits of vaccination include heightened resilience against future outbreaks, improved educational and economic stability resulting from reduced school and work absenteeism, as well as fewer healthcare visits and decreased hospitalizations due to preventable illnesses.
Celebrating 50 Years of Education, Prevention, and Impact
For 50 years, the National Foundation for Infectious Diseases (NFID) has been educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan …
The Lifesaving Impact of Vaccines for Children
As NFID celebrates its 50th anniversary, Past President Walter A. Orenstein, MD, reflects on the 30th anniversary of the Vaccines for Children program
National Immunization Awareness Month Resource Round-Up
The National Foundation for Infectious Diseases has compiled resources for NIAM (and all year-round) to raise awareness about vaccine-preventable diseases and the importance of disease prevention
ID News Round-Up
Advances in infectious disease prevention and treatment have made headlines on COVID-19, flu, HPV, RSV, and more
Don’t Let Norovirus Ruin Summer Plans
Learn how to prevent this stomach bug and what to do if you get sick
Schaffner Report: What Adults Should Know about New RSV Vaccines
NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton, CAE, about new vaccines for RSV
Highlights and Key Takeaways from 2023 Annual Conference on Vaccinology Research
The 2023 ACVR featured new scientific findings on COVID-19, respiratory syncytial virus (RSV), influenza, and more, as decades of research are paying off